Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Vz, volume of distribution during the terminal phase"'
Autor:
Jin Gyu Jung, Sunghyun Kim, Bum Soo Kim, Anca Streinu-Cercel, Oana Săndulescu, Da Bee Jeon, Adrian Streinu-Cercel, Seul Gi Lee, Sang Joon Lee, Yeon Sook Kim, Yeo Jin Lee, Jin Yong Kim, Yeon Mi Lee, Min Kyung Kim, Jae-Hyeong Park, Jang Hee Hong, Jeong Eun Park, Young Rock Jang, Na Hyun Jung
Publikováno v:
Clinical Therapeutics
PURPOSE: Neutralizing antibodies can reduce SARS-CoV-2 cellular entry, viral titers, and pathologic damage. CT-P59 (regdanvimab), a SARS-CoV-2 neutralizing monoclonal antibody, was examined in 2 randomized, double-blind, placebo-controlled, single as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be168aec276ef873b11c98eb98586b40
https://doi.org/10.1016/j.clinthera.2021.08.009
https://doi.org/10.1016/j.clinthera.2021.08.009
